Rapamycin Reduces Bax Levels in Alzheimer's Patients

P

Physionic YouTube channel discusses the effects of Rapamycin on Alzheimer's disease.

Quotes From Source

“Rapamycin eliminates the increase in Bax.”

Story of claim

Rapamycin reduces pro-apoptotic proteins like Bax in Alzheimer's disease models, potentially preventing mitochondrial damage and cell death. This could slow disease progression.

  • Goal: To reduce the impact of Alzheimer's by targeting mitochondrial health.
  • Proof: Rapamycin decreases Bax protein levels, which are linked to mitochondrial damage in Alzheimer's, potentially mitigating cell death pathways.
  • Nuances:
    • Doubling in Bax is present in Alzheimer's condition.
    • Pro-apoptotic proteins encourage pore formation on mitochondria.
  • Impact on Life: Potential reduction in Alzheimer's progression through the mitigation of cell death pathways.

Investments

  • Price: Not mentioned
  • Time: Research and trials needed for validation.
  • Effort: Requires substantial research and clinical trials.

Risks

Potential unknown side effects due to lack of extensive human studies.

Get Started 🚀

  • Review current research on Rapamycin and Alzheimer's.
  • Consult with a healthcare provider for potential trials.
  • Monitor ongoing studies for updates on effectiveness.

Brogevity AI can make mistakes. Check important info.

Reference Video